[EN] NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRAZOLO[1,5-A]PYRIMIDINE UTILISÉS COMME INHIBITEURS DE MTOR
申请人:SCHERING CORP
公开号:WO2012027236A1
公开(公告)日:2012-03-01
The present invention relates to certain pyrazolo[1,5-a]pyrimidine compounds of Formula (I) as inhibitors of mammalian Target Of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP. The compounds may be used in the treatment of cancer and other disorders where mTOR is deregulated. The present invention further provides pharmaceutical compositions comprising the pyrazolo[1,5-a]pyrimidine compounds.
BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
申请人:Hilpert Kurt
公开号:US20140073651A1
公开(公告)日:2014-03-13
The invention relates to benzamide derivatives of formula (I),
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, n and Y are as defined in the description, their preparation and their use as pharmaceutically active compounds.
[EN] BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE BENZAMIDE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR P2X7
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2012114268A1
公开(公告)日:2012-08-30
The invention relates to benzamide derivatives of formula (I),wherein R1, R2, R3, R4, R5, R6, n and Y are as defined in the description, their preparation and their use as pharmaceutically active compounds.
A new uncatalyzed method for the preparation of cyanohydrin O-alkyl ethers was developed using the high-pressure-promoted reaction of acetals with trimethylsilylcyanide in nitromethane.
Bismuth bromide was found to work efficiently as a versatile catalyst for the cyanation and allylation of carbonyl compounds and acetals with organosilicon reagents, affording the corresponding alcohols and ethers in high yields.